Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gt Biopharma, Inc. (OXIS.OB) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gt Biopharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 109657.
Total stock buying since 2016: $76,233.
Total stock sales since 2016: $205,031,494,546.
Total stock option exercises since 2016: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 100,000 | $50,000 | 0 | $0 | 0 | $0 |
| 2020 | 5,083 | $26,233 | 7,284,028 | $243,570 | 0 | $0 |
| 2019 | 0 | $0 | 976,980 | $976 | 0 | $0 |
| 2016 | 0 | $0 | 675,000 | $205,031,250,000 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-04 | 100,000 | $50,000 | 0 | $0 | 0 | $0 |
| 2020-12 | 1,815 | $15,972 | 780,000 | $237,067 | 0 | $0 |
| 2020-11 | 3,268 | $10,261 | 0 | $0 | 0 | $0 |
| 2020-06 | 0 | $0 | 4,234,320 | $4,234 | 0 | $0 |
| 2020-05 | 0 | $0 | 2,269,708 | $2,269 | 0 | $0 |
| 2019-02 | 0 | $0 | 976,980 | $976 | 0 | $0 |
| 2016-04 | 0 | $0 | 675,000 | $205,031,250,000 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-04-11 | Breen Michael Martin (Executive Chairman/Interim CEO) | Buy | 50,000 | .50 | 25,000 |
| 2023-04-06 | Ohri Manu (CFO & Secretary) | Buy | 50,000 | .50 | 25,000 |
| 2020-12-22 | Wendel Bruce | Buy | 1,815 | 8.80 | 15,972 |
| 2020-12-22 | Weldon Steven W (Other) | Sale | 47,978 | .40 | 19,191 |
| 2020-12-21 | Weldon Steven W (Other) | Sale | 135,722 | .32 | 43,838 |
| 2020-12-18 | Weldon Steven W (Other) | Sale | 50,000 | .30 | 15,000 |
| 2020-12-17 | Weldon Steven W (Other) | Sale | 100,000 | .30 | 30,500 |
| 2020-12-16 | Weldon Steven W (Other) | Sale | 50,000 | .30 | 15,000 |
| 2020-12-15 | Weldon Steven W (Other) | Sale | 150,000 | .31 | 46,050 |
| 2020-12-14 | Weldon Steven W (Other) | Sale | 146,300 | .29 | 41,988 |
| 2020-12-11 | Weldon Steven W (Other) | Sale | 100,000 | .26 | 25,500 |
| 2020-11-16 | Wendel Bruce | Buy | 3,268 | 3.14 | 10,261 |
| 2020-06-02 | Cataldo Tony (CEO) | Sale | 4,234,320 | .00 | 4,234 |
| 2020-05-13 | Weldon Steven W (CFO) | Sale | 2,269,708 | .00 | 2,269 |
| 2019-02-06 | Cataldo Tony (Director) | Sale | 800,000 | .00 | 800 |
| 2019-02-01 | Urbanski Raymond W. (CEO) | Sale | 176,980 | .00 | 176 |
| 2016-04-04 | Bristol Investment Fund Ltd | Sale | 675,000 | 303,750.00 | 205,031,250,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of OXIS.OB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gt Biopharma, Inc. (symbol OXIS.OB, CIK number 109657) see the Securities and Exchange Commission (SEC) website.